Intec Pharma Ltd.
10 Hartom Street (Rmpe Building)
P.O.Box 45219
Jerusalem
91450
Tel: 00972-2-5864657
Fax: 00972-2-5869176
Website: http://www.intecpharma.com/
Email: info@intecpharma.com
110 articles about Intec Pharma Ltd.
-
Intec Pharma To Sponsor Investigator Meeting For Pivotal Phase III Study Of Accordion Pill Carbidopa/Levodopa In Advanced Parkinson's Disease Patients
11/10/2016
-
Intec Pharma Announces Protocol Amendment To Phase III Study Of Accordion Pill Carbidopa/Levodopa In Advanced Parkinson's Disease Patients
11/7/2016
-
Intec Pharma Granted Chinese Patent For Accordion Pill Carbidopa/Levodopa
10/31/2016
-
Intec Pharma To Participate In Upcoming September Conferences
9/8/2016
-
Intec Pharma Granted European Patent for Accordion Pill–Carbidopa / Levodopa
9/6/2016
-
Intec Pharma Reports First Half 2016 Financial Results
9/1/2016
-
Intec Pharma To Pursue Development Of Accordion Pill For Cannabinoid Therapies
8/4/2016
-
Intec Pharma CFO Resigns Due to Personal Reasons
6/3/2016
-
Intec Pharma Ltd. Receives Approval For US$5.2 Million Grant
5/31/2016
-
Intec Pharma Ltd. To Nominate Dr. John W. Kozarich As Chairman Of The Board Of Directors
5/16/2016
-
Intec Pharma Ltd. Appoints VP Of Clinical And Regulatory Affairs
5/3/2016
-
Intec Pharma Ltd. Expands Intellectual Property For AP-CDLD With Patent In South Korea
4/6/2016
-
Intec Pharma Ltd. Enrolls First Patient In Pivotal Phase III Clinical Trial Of AP-CDLD For Advanced Parkinson's Disease Patients
4/4/2016
-
Intec Pharma Ltd. Release: Mr. Zvika Joseph To Step Down As Chairman Of The Board Of Directors
3/18/2016
-
Intec Pharma Ltd. Reports 2015 Fourth Quarter And Full-Year Financial Results
3/15/2016
-
Intec Pharma Ltd.: Notice Of Special General Meeting Of Shareholders
3/14/2016
-
Intec Pharma Ltd. Announces Availability Of Its Annual Report On Form 20-F Through Its Website
3/14/2016
-
Intec Pharma Ltd. Completed A Phase I Clinical Trial With Its Third Pipeline Product
3/11/2016
-
Intec Pharma Ltd. To Present At Biotech Showcase 2016
1/5/2016
-
Intec Pharma Ltd. Further Expands Intellectual Property With A New Patent For The Accordion Pill Zaleplon In Europe
12/16/2015